Abalone Bio is a biotechnology company that leverages engineered biology and machine learning to create target-activating antibodies for challenging diseases. The company provides its AI-powered antibody discovery platform and services to pharmaceutical and biotech partners for their discovery campaigns. Abalone Bio is also developing its own pipeline of antibody therapeutics for indications such as peripheral neuropathy, liver fibrosis, and obesity.
$1.47M
4
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos